Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite

Deepika Kannan, Nisha Yadav, Shakeel Ahmad, Pragya Namdev, Souvik Bhattacharjee, Bimlesh Lochab, Shailja Singh

EBioMedicine · 2019 · 79 citations · 47 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: within the parasitic food vacuole for enhanced ROS spurt. METHODS: , production of reactive oxygen species and parasite biomolecule damage by iron oxide nanoparticle fortified artesunate was studied using various biochemical, biophysical, ultra-structural and fluorescence microscopy. For determining the efficacy of ATA-IONP+ART on resistant parasite ring survival assay was performed. RESULTS: and led to retarded growth of P. falciparum with significant damage to macromolecules mediated via enhanced ROS production. Similarly, preclinical In vivo studies also signified a radical reduction in parasitemia with ~8-10-fold reduced dosage of artesunate when fortified with iron oxide nanoparticles. Importantly, the ATA-IONP combination was efficacious against artemisinin-resistant parasites. INTERPRETATION: Surface coated iron-oxide nanoparticle fortified artesunate can be developed into a potent therapeutic agent towards multidrug-resistant and artemisinin-resistant malaria in humans. FUND: This study is supported by the Centre for Study of Complex Malaria in India funded by the National Institute of Health, USA.

References

47